Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Interleukin-6 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Interleukin-5 Receptor alpha Subunit < Interleukin-6 < Interleukin-6 Receptor alpha Subunit  Facettes :

List of bibliographic references indexed by Interleukin-6

Number of relevant bibliographic references: 487.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000B00 (2019) Yueh-Shan Weng [Taïwan] ; Hong-Yu Tseng [Taïwan] ; Yen-An Chen [Taïwan] ; Pei-Chun Shen [Taïwan] ; Aushia Tanzih Al Haq [Taïwan] ; Li-Mei Chen [Taïwan] ; Yi-Chung Tung [Taïwan] ; Hsin-Ling Hsu [Taïwan]MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
000B57 (2019) Shinji Akioka [Japon]Interleukin-6 in juvenile idiopathic arthritis.
000B68 (2019) Kathryn A. Radigan [États-Unis] ; Trevor T. Nicholson [États-Unis] ; Lynn C. Welch [États-Unis] ; Monica Chi [États-Unis] ; Luciano Amarelle [États-Unis] ; Martín Angulo [États-Unis] ; Masahiko Shigemura [États-Unis] ; Atsuko Shigemura [États-Unis] ; Constance E. Runyan [États-Unis] ; Luisa Morales-Nebreda [États-Unis] ; Harris Perlman [États-Unis] ; Ermelinda Ceco [États-Unis] ; Emilia Lecuona [États-Unis] ; Laura A. Dada [États-Unis] ; Alexander V. Misharin [États-Unis] ; Gokhan M. Mutlu [États-Unis] ; Jacob I. Sznajder [États-Unis] ; G R Scott Budinger [États-Unis]Influenza A Virus Infection Induces Muscle Wasting via IL-6 Regulation of the E3 Ubiquitin Ligase Atrogin-1.
000C20 (2019) N. Kamiya [Japon] ; G. Kuroyanagi [États-Unis] ; O. Aruwajoye [États-Unis] ; H K W. Kim [États-Unis]IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice.
000C21 (2019) Hassan Yousefi [Iran] ; Majid Momeny [Iran] ; Seyed H. Ghaffari [Iran] ; Nazanin Parsanejad [Iran] ; Arash Poursheikhani [Iran] ; Sepehr Javadikooshesh [Iran] ; Ghazaleh Zarrinrad [Iran] ; Fatemeh Esmaeili [Iran] ; Zivar Alishahi [Iran] ; Zahra Sabourinejad [Iran] ; Ghazaleh Sankanian [Iran] ; Sahar Shamsaiegahkani [Iran] ; Davood Bashash [Iran] ; Narjes Shahsavani [Canada] ; Javad Tavakkoly-Bazzaz [Iran] ; Kamran Alimoghaddam [Iran] ; Ardeshir Ghavamzadeh [Iran]IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer.
000C23 (2019) Atsushi Ogata [Japon] ; Yasuhiro Kato [Japon] ; Shinji Higa [Japon] ; Kazuyuki Yoshizaki [Japon]IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review.
000D74 (2019) Ignatios Ikonomidis [Grèce] ; George Pavlidis [Grèce] ; Pelagia Katsimbri [Grèce] ; Ioanna Andreadou [Grèce] ; Helen Triantafyllidi [Grèce] ; Maria Tsoumani [Grèce] ; Maria Varoudi [Grèce] ; Dimitrios Vlastos [Grèce] ; George Makavos [Grèce] ; Gavriella Kostelli [Grèce] ; Dimitrios Enas [Grèce] ; John Lekakis [Grèce] ; John Parissis [Grèce] ; Dimitrios Boumpas [Grèce] ; Dimitrios Alexopoulos [Grèce] ; Efstathios Iliodromitis [Grèce]Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function.
000D96 (2019) Anna Leszczynska [Espagne] ; Blanca Molins [Espagne] ; Estrella Fernández [Espagne] ; Alfredo Adán [Espagne] ; Santiago Ortiz-Perez [Espagne]Cytokine production in thyroid eye disease: in vitro effects of dexamethasone and IL-6 blockade with tocilizumab.
001006 (2019) Yasuaki Okuda [Japon]AA amyloidosis - Benefits and prospects of IL-6 inhibitors.
001011 (2019) Cécile Luxembourger [France] ; Adeline Ruyssen-Witrand [France] ; Chayma Ladhari [France] ; Cécile Rittore [France] ; Yannick Degboe [France] ; Jean-Francis Maillefert [France] ; Philippe Gaudin [France] ; Hubert Marotte [France] ; Daniel Wendling [France] ; Christian Jorgensen [France] ; Alain Cantagrel [France] ; Arnaud Constantin [France] ; Delphine Nigon [France] ; Isabelle Touitou [France] ; Jacques-Eric Gottenberg [France] ; Yves-Marie Pers [France]A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients.
001024 (2019) Tomohiro Koga [Japon] ; Remi Sumiyoshi [Japon] ; Atsushi Kawakami [Japon] ; Kazuyuki Yoshizaki [Japon]A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
001081 (2018) Hirofumi Jono[Establishing Individualized Medicine for Intractable Cancer Based on Clinical Molecular Pathogenesis].
001092 (2018) Chuanyin Sun ; Yingwan Luo [République populaire de Chine] ; Hongyan Tong [République populaire de Chine] ; Guanhua Xu ; Jin LinUsefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review.
001109 (2018) Frits Van Rhee [États-Unis] ; Amy Greenway [États-Unis] ; Katie Stone [États-Unis]Treatment of Idiopathic Castleman Disease.
001126 (2018) Matthew B. Carroll [États-Unis]Tocilizumab in the treatment of myocardial infarction.
001134 (2018) Shirin Hamed Azzam ; Swan Kang ; Mario Salvi ; Daniel G. EzraTocilizumab for thyroid eye disease.
001135 (2018) Michael Schirmer [Autriche] ; Francesco Muratore [Italie] ; Carlo Salvarani [Italie]Tocilizumab for the treatment of giant cell arteritis.
001144 (2018) Maxime Samson [France] ; Hervé Devilliers [France] ; Kim Heang Ly [France] ; François Maurier [France] ; Boris Bienvenu [France] ; Benjamin Terrier [France] ; Pierre Charles [France] ; Loïc Guillevin [France] ; Jean-François Besancenot [France] ; Eric Liozon [France] ; Anne Laure Fauchais [France] ; Romaric Loffroy [France] ; Christine Binquet [France] ; Sylvain Audia [France] ; Raphaèle Seror [France] ; Xavier Mariette [France] ; Bernard Bonnotte [France]Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
001149 (2018) Christopher P. Denton [Royaume-Uni] ; Voon H. Ong [Royaume-Uni] ; Shiwen Xu [Royaume-Uni] ; Haiyin Chen-Harris [États-Unis] ; Zora Modrusan [États-Unis] ; Robert Lafyatis [États-Unis] ; Dinesh Khanna [États-Unis] ; Angelika Jahreis [États-Unis] ; Jeffrey Siegel [États-Unis] ; Thierry Sornasse [États-Unis]Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
001152 (2018) Regitse H Jgaard Christensen [Danemark] ; Anne-Sophie Wedell-Neergaard [Danemark] ; Louise Lang Lehrskov [Danemark] ; Grit Elster Leg Rd [Danemark] ; Emma Berndt Dorph [Danemark] ; Stine Nymand [Danemark] ; Maria Korf Ball [Danemark] ; Morten Zacho [Danemark] ; Robin Christensen [Danemark] ; Helga Ellingsgaard [Danemark] ; Jaya Birgitte Rosenmeier [Danemark] ; Rikke Krogh-Madsen [Danemark] ; Bente Klarlund Pedersen [Danemark] ; Kristian Karstoft [Danemark]The role of exercise combined with tocilizumab in visceral and epicardial adipose tissue and gastric emptying rate in abdominally obese participants: protocol for a randomised controlled trial.
001157 (2018) Cesar Diaz-Torne [Espagne] ; Maria Dels Angels Ortiz [Espagne] ; Patricia Moya [Espagne] ; Maria Victoria Hernandez [Espagne] ; Delia Reina [Espagne] ; Ivan Castellvi [Espagne] ; Juan Jose De Agustin [Espagne] ; Diana De La Fuente [Espagne] ; Hector Corominas [Espagne] ; Raimon Sanmarti [Espagne] ; Carlos Zamora [Espagne] ; Elisabet Cant [Espagne] ; Silvia Vidal [Espagne]The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Interleukin-6" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Interleukin-6" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Interleukin-6
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021